New CFO to Lead Financial Strategy and Global Compliance at C-Path
TUCSON, Ariz., March 27, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Paul E. Edmeier as its new Chief Financial Officer. Edmeier brings to C-Path a comprehensive background in financial management and strategic planning from both the nonprofit and private sectors.
In his new role, Edmeier will be instrumental in overseeing C-Path’s financial operations globally. He will be responsible for leading strategic financial initiatives, ensuring compliance with critical financial regulations, and enhancing the organization’s capacity for broad-scale collaborative projects. His expertise will be vital in aligning financial strategies with C-Path’s mission to accelerate the development of health innovations.
“Paul has played a pivotal role in steering organizations through complex financial landscapes, proving instrumental in building their strategic and fiscal operations,” said Klaus Romero, M.D., M.S., FCP, CEO of C-Path. “His deep commitment to financial excellence and his ability to engage effectively with stakeholders across the board have consistently and positively impacted the organizations he has served. Paul’s appointment as CFO ensures that we continue to solidify our value proposition, manage growth, and continue our station as the leader in the development of global health standards.”
Expressing enthusiasm for his new role, Edmeier stated, “I am honored to step into the role of CFO at C-Path, an organization renowned for its pioneering approach to accelerating drug development. The opportunity to further the financial strategies that support such significant work is both inspiring and motivating. I look forward to contributing to C-Path’s mission and impacting global health outcomes for the greater good.”
Edmeier’s appointment is effective immediately, and he is set to begin directing C-Path’s financial strategies to support and sustain the institute’s ambitious goals.
About Critical Path Institute
Founded in 2005, as a public-private partnership in response to the FDA’s Critical Path Initiative, Critical Path Institute® (C-Path) celebrates its 20th anniversary as a vital, independent, nonprofit. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
Media Contacts:
Roxan Triolo Olivas
C-Path
520.954.1634
rolivas@c-path.org
Kissy Black
C-Path
615.310.1894
kblack@c-path.org